ClinConnect ClinConnect Logo
Search / Trial NCT06612567

Normal Variants and Pitfalls of 18F_FDG PET/CT in Pediatric Oncology

Launched by ASSIUT UNIVERSITY · Sep 22, 2024

Trial Information

Current as of June 23, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how 18F-FDG PET/CT scans can sometimes show normal differences in children and teens with cancer, as well as some common mistakes in reading the results. The goal is to help doctors better understand these scans so they can make more accurate decisions about a patient's care.

The trial is open to all pediatric cancer patients who are referred for this type of imaging study. If you or your child is a cancer patient aged 18 years or older, you may be eligible to participate. Participants will undergo a PET/CT scan, which is a special imaging test that helps doctors see how the body is functioning. It's important to note that patients who are severely ill or have very low blood sugar levels will not be included in the study. This research aims to improve the understanding of how PET scans work in children with cancer, ultimately leading to better care and treatment options.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All Pediatric Cancer patients referred to nuclear medicine unit to do 18F-FDG PET/CT study.
  • All patients \> or = 18 years.
  • Exclusion Criteria:
  • Severely ill patients. Patients with glucose level \< 200 mg/dl.

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported